312 related articles for article (PubMed ID: 18428025)
1. Beneficial synergistic interactions of TNF-alpha and IL-6 in C2 skeletal myoblasts--potential cross-talk with IGF system.
Al-Shanti N; Saini A; Faulkner SH; Stewart CE
Growth Factors; 2008 Apr; 26(2):61-73. PubMed ID: 18428025
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis.
Foulstone EJ; Meadows KA; Holly JM; Stewart CE
J Cell Physiol; 2001 Nov; 189(2):207-15. PubMed ID: 11598906
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts.
Meadows KA; Holly JM; Stewart CE
J Cell Physiol; 2000 Jun; 183(3):330-7. PubMed ID: 10797307
[TBL] [Abstract][Full Text] [Related]
4. Pro- and anti-apoptotic roles for IGF-I in TNF-alpha-induced apoptosis: a MAP kinase mediated mechanism.
Saini A; Al-Shanti N; Faulkner SH; Stewart CE
Growth Factors; 2008 Oct; 26(5):239-53. PubMed ID: 18651291
[TBL] [Abstract][Full Text] [Related]
5. Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol.
Saini A; Al-Shanti N; Sharples AP; Stewart CE
Exp Physiol; 2012 Mar; 97(3):400-18. PubMed ID: 22125309
[TBL] [Abstract][Full Text] [Related]
6. C2 and C2C12 murine skeletal myoblast models of atrophic and hypertrophic potential: relevance to disease and ageing?
Sharples AP; Al-Shanti N; Stewart CE
J Cell Physiol; 2010 Oct; 225(1):240-50. PubMed ID: 20506232
[TBL] [Abstract][Full Text] [Related]
7. Role of insulin-like growth factor binding protein-3 (IGFBP-3) in the differentiation of primary human adult skeletal myoblasts.
Foulstone EJ; Savage PB; Crown AL; Holly JM; Stewart CE
J Cell Physiol; 2003 Apr; 195(1):70-9. PubMed ID: 12599210
[TBL] [Abstract][Full Text] [Related]
8. Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: roles of IGF-I and TNFalpha.
Foulstone EJ; Huser C; Crown AL; Holly JM; Stewart CE
Exp Cell Res; 2004 Mar; 294(1):223-35. PubMed ID: 14980516
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.
Layne MD; Farmer SR
Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964
[TBL] [Abstract][Full Text] [Related]
10. Multifaceted roles of TNF-alpha in myoblast destruction: a multitude of signal transduction pathways.
Stewart CE; Newcomb PV; Holly JM
J Cell Physiol; 2004 Feb; 198(2):237-47. PubMed ID: 14603526
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha.
Fernández-CelemÃn L; Pasko N; Blomart V; Thissen JP
Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1279-90. PubMed ID: 12388149
[TBL] [Abstract][Full Text] [Related]
13. Isolation and validation of human prepubertal skeletal muscle cells: maturation and metabolic effects of IGF-I, IGFBP-3 and TNFalpha.
Grohmann M; Foulstone E; Welsh G; Holly J; Shield J; Crowne E; Stewart C
J Physiol; 2005 Oct; 568(Pt 1):229-42. PubMed ID: 16081485
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of IL-6 on IGF-1 activity in skeletal myoblasts could be mediated by the activation of SOCS-3.
Al-Shanti N; Stewart CE
J Cell Biochem; 2012 Mar; 113(3):923-33. PubMed ID: 22033984
[TBL] [Abstract][Full Text] [Related]
15. Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor.
Shen WH; Zhou JH; Broussard SR; Freund GG; Dantzer R; Kelley KW
Cancer Res; 2002 Aug; 62(16):4746-56. PubMed ID: 12183434
[TBL] [Abstract][Full Text] [Related]
16. Retrovirally mediated overexpression of insulin-like growth factor binding protein 4: evidence that insulin-like growth factor is required for skeletal muscle differentiation.
Damon SE; Haugk KL; Birnbaum RS; Quinn LS
J Cell Physiol; 1998 Apr; 175(1):109-20. PubMed ID: 9491786
[TBL] [Abstract][Full Text] [Related]
17. ERK2 is required for efficient terminal differentiation of skeletal myoblasts.
Li J; Johnson SE
Biochem Biophys Res Commun; 2006 Jul; 345(4):1425-33. PubMed ID: 16729973
[TBL] [Abstract][Full Text] [Related]
18. The IL-6/sIL-6R treatment of a malignant melanoma cell line enhances susceptibility to TNF-alpha-induced apoptosis.
Wagley Y; Yoo YC; Seo HG; Rhee MH; Kim TH; Kang KW; Nah SY; Oh JW
Biochem Biophys Res Commun; 2007 Mar; 354(4):985-91. PubMed ID: 17274948
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-5 potentiates the growth response of Caco-2 cells to IGF-II: a role in colonic carcinogenesis complicating ulcerative colitis?
Makins R; Ballinger A
Growth Horm IGF Res; 2005 Jun; 15(3):215-22. PubMed ID: 15935984
[TBL] [Abstract][Full Text] [Related]
20. 17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells.
Pandini G; Genua M; Frasca F; Squatrito S; Vigneri R; Belfiore A
Cancer Res; 2007 Sep; 67(18):8932-41. PubMed ID: 17875736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
